NATCO Pharma Limited (NATCOPHARM.NS)
INR 775.5
(3.88%)
INR 775.5
(3.88%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 13.88 Billion INR | 94.09% |
| 2022 | 7.15 Billion INR | 320.76% |
| 2021 | 1.7 Billion INR | -61.44% |
| 2020 | 4.4 Billion INR | -4.32% |
| 2019 | 4.6 Billion INR | -28.49% |
| 2018 | 6.44 Billion INR | -7.44% |
| 2017 | 6.96 Billion INR | 43.25% |
| 2016 | 4.86 Billion INR | 213.19% |
| 2015 | 1.55 Billion INR | 15.27% |
| 2014 | 1.34 Billion INR | 31.03% |
| 2013 | 1.02 Billion INR | 42.95% |
| 2012 | 718.69 Million INR | 20.57% |
| 2011 | 596.08 Million INR | 11.39% |
| 2010 | 535.11 Million INR | 9.84% |
| 2009 | 487.18 Million INR | 10.79% |
| 2008 | 439.71 Million INR | 8.54% |
| 2007 | 405.13 Million INR | 32.99% |
| 2006 | 304.62 Million INR | 28.03% |
| 2005 | 237.93 Million INR | 1428.36% |
| 2004 | 15.56 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 FY | 13.88 Billion INR | 94.09% |
| 2023 Q4 | 6.68 Billion INR | 73.05% |
| 2023 Q1 | 3.69 Billion INR | -12.21% |
| 2023 Q2 | 2.12 Billion INR | -42.36% |
| 2023 Q3 | 3.86 Billion INR | 81.62% |
| 2022 Q3 | 2.75 Billion INR | 342.7% |
| 2022 Q1 | 568 Million INR | -82.27% |
| 2022 Q4 | 4.2 Billion INR | 52.39% |
| 2022 FY | 7.15 Billion INR | 320.76% |
| 2022 Q2 | 623 Million INR | 9.68% |
| 2021 Q3 | -505 Million INR | -162.81% |
| 2021 FY | 1.7 Billion INR | -61.44% |
| 2021 Q1 | 651 Million INR | -13.2% |
| 2021 Q2 | 804 Million INR | 23.5% |
| 2021 Q4 | 3.2 Billion INR | 734.46% |
| 2020 Q1 | 2.02 Billion INR | 64.82% |
| 2020 Q4 | 750 Million INR | 41.51% |
| 2020 Q3 | 530 Million INR | -15.47% |
| 2020 Q2 | 627 Million INR | -69.02% |
| 2020 FY | 4.4 Billion INR | -4.32% |
| 2019 Q4 | 1.22 Billion INR | 30.5% |
| 2019 FY | 4.6 Billion INR | -28.49% |
| 2019 Q1 | 1.19 Billion INR | -16.9% |
| 2019 Q2 | 1.04 Billion INR | -12.18% |
| 2019 Q3 | 941 Million INR | -9.95% |
| 2018 Q2 | 1.59 Billion INR | -12.6% |
| 2018 Q1 | 1.82 Billion INR | 0.5% |
| 2018 Q4 | 1.43 Billion INR | 18.54% |
| 2018 FY | 6.44 Billion INR | -7.44% |
| 2018 Q3 | 1.2 Billion INR | -24.26% |
| 2017 Q2 | 2.17 Billion INR | 156.49% |
| 2017 Q4 | 1.81 Billion INR | -39.45% |
| 2017 Q3 | 2.99 Billion INR | 37.89% |
| 2017 Q1 | 848 Million INR | -9.79% |
| 2017 FY | 6.96 Billion INR | 43.25% |
| 2016 FY | 4.86 Billion INR | 213.19% |
| 2016 Q1 | 665 Million INR | 40.0% |
| 2016 Q2 | 1.95 Billion INR | 193.38% |
| 2016 Q4 | 940 Million INR | -46.8% |
| 2016 Q3 | 1.76 Billion INR | -9.43% |
| 2015 Q3 | 628 Million INR | 70.05% |
| 2015 Q1 | 292.9 Million INR | 4.35% |
| 2015 Q4 | 475 Million INR | -24.36% |
| 2015 FY | 1.55 Billion INR | 15.27% |
| 2015 Q2 | 369.3 Million INR | 26.08% |
| 2014 Q2 | 143.4 Million INR | -55.7% |
| 2014 Q4 | 280.7 Million INR | -48.44% |
| 2014 Q3 | 544.45 Million INR | 279.68% |
| 2014 Q1 | 323.7 Million INR | -3.26% |
| 2014 FY | 1.34 Billion INR | 31.03% |
| 2013 Q2 | 298.8 Million INR | 11.0% |
| 2013 Q4 | 334.6 Million INR | 39.33% |
| 2013 FY | 1.02 Billion INR | 42.95% |
| 2013 Q1 | 269.2 Million INR | 23.6% |
| 2013 Q3 | 240.14 Million INR | -19.63% |
| 2012 FY | 718.69 Million INR | 20.57% |
| 2012 Q3 | 113.29 Million INR | -49.85% |
| 2012 Q2 | 225.9 Million INR | 7.62% |
| 2012 Q1 | 209.9 Million INR | 22.96% |
| 2012 Q4 | 217.8 Million INR | 92.25% |
| 2011 FY | 596.08 Million INR | 11.39% |
| 2011 Q2 | 170 Million INR | 6.65% |
| 2011 Q3 | 126.48 Million INR | -25.6% |
| 2011 Q4 | 170.7 Million INR | 34.96% |
| 2011 Q1 | 159.4 Million INR | 0.0% |
| 2010 FY | 535.11 Million INR | 9.84% |
| 2009 FY | 487.18 Million INR | 10.79% |
| 2008 FY | 439.71 Million INR | 8.54% |
| 2007 FY | 405.13 Million INR | 32.99% |
| 2006 FY | 304.62 Million INR | 28.03% |
| 2005 FY | 237.93 Million INR | 1428.36% |
| 2004 FY | 15.56 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | -125.439% |
| Hester Biosciences Limited | 188.89 Million INR | -7249.78% |
| Aarti Drugs Limited | 1.71 Billion INR | -709.891% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -540.059% |
| Albert David Limited | 754.2 Million INR | -1740.756% |
| Alembic Limited | 2.68 Billion INR | -416.828% |
| Alkem Laboratories Limited | 17.95 Billion INR | 22.691% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | -18793.834% |
| Bajaj HealthCare Limited | -837.93 Million INR | 1756.819% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -195655.781% |
| Brooks Laboratories Limited | -195.91 Million INR | 7186.092% |
| Eris Lifesciences Limited | 3.91 Billion INR | -254.174% |
| FDC Limited | 3.05 Billion INR | -354.847% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | -194.826% |
| Gufic Biosciences Limited | 861.35 Million INR | -1511.761% |
| Hikal Limited | 696 Million INR | -1894.684% |
| Ind-Swift Limited | 142.31 Million INR | -9655.258% |
| Innova Captab Limited | 943.45 Million INR | -1371.514% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -932.731% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -6080.386% |
| Jubilant Pharmova Limited | 771 Million INR | -1700.649% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | -1387.918% |
| Lupin Limited | 19.14 Billion INR | 27.484% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 15403.637% |
| Medico Remedies Limited | 82.9 Million INR | -16644.865% |
| Morepen Laboratories Limited | 961.59 Million INR | -1343.741% |
| Nectar Lifesciences Limited | 49.95 Million INR | -27693.794% |
| Orchid Pharma Limited | 921.66 Million INR | -1406.296% |
| Procter & Gamble Health Limited | 2 Billion INR | -590.765% |
| RPG Life Sciences Limited | 876.6 Million INR | -1483.733% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -9407.992% |
| Sigachi Industries Limited | 571.8 Million INR | -2327.938% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 344.682% |
| Suven Pharmaceuticals Limited | 3 Billion INR | -362.334% |
| Themis Medicare Limited | 435.23 Million INR | -3089.749% |
| Unichem Laboratories Limited | -704.74 Million INR | 2069.938% |
| Vaishali Pharma Limited | 7.18 Million INR | -193014.48% |
| Wanbury Limited | 559.56 Million INR | -2381.043% |
| Windlas Biotech Limited | 581.87 Million INR | -2285.928% |
| ZIM Laboratories Limited | 172.46 Million INR | -7949.796% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | -229.793% |
| Ipca Laboratories Limited | 5.47 Billion INR | -153.64% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 85.503% |
| Venus Remedies Limited | 284.9 Million INR | -4772.801% |
| Sakar Healthcare Limited | 116.7 Million INR | -11795.398% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 56.246% |
| Divi's Laboratories Limited | 16 Billion INR | 13.231% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -759.575% |
| Mankind Pharma Limited | 19.12 Billion INR | 27.424% |
| Sequent Scientific Limited | -358.69 Million INR | 3970.473% |
| Laurus Labs Limited | 1.6 Billion INR | -764.715% |
| Neuland Laboratories Limited | 3 Billion INR | -362.645% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | -151.218% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 192.451% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 64.029% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -2986.991% |
| Wockhardt Limited | -4.63 Billion INR | 399.849% |
| Bal Pharma Limited | 73.92 Million INR | -18680.607% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 75.068% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -1739.927% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | -9473.822% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | -203.726% |
| Shilpa Medicare Limited | 318.74 Million INR | -4255.56% |
| Valiant Laboratories Limited | 3.19 Million INR | -434286.733% |
| Ajanta Pharma Limited | 8.16 Billion INR | -70.099% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | -29541.304% |
| Granules India Limited | 4.05 Billion INR | -242.528% |
| Medicamen Biotech Limited | 109.31 Million INR | -12600.576% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -5384.274% |
| Piramal Enterprises Limited | -16.83 Billion INR | 182.464% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 16.185% |
| Suven Life Sciences Limited | -1.05 Billion INR | 1421.23% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 7137.063% |
| Strides Pharma Science Limited | -706.14 Million INR | 2066.041% |
| Indoco Remedies Limited | 984.6 Million INR | -1310.013% |
| Alpa Laboratories Limited | 167.76 Million INR | -8175.266% |
| Lasa Supergenerics Limited | -217.3 Million INR | 6488.687% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 458.536% |